Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengnan Bao

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|January 26, 2026
Maintenance therapy in hormone receptor-positive and human epidermal growth factor receptor 2-positive metastatic breast cancer: a real-world multicenter retrospective studyShengnan Bao, Jia Chen, Yongmei Yin
Ecotoxicology and Environmental Safety|February 24, 2022
Exploration of anti-chromium mechanism of marine Penicillium janthinellum P1 through combinatorial transcriptomic analysis and WGCNAShengnan Bao, Jiawei Mu, Pingchuan Yin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 26, 2024
Clinical, pathological and gene expression profiling of estrogen receptor discordance in breast cancerXi Wang, Shengnan Bao, Mengping Jiang, et al.
The Breast Journal|June 17, 2022
Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding?Caiyun Yan, Jianling Bai, Shengnan Bao, et al.
Frontiers in Pharmacology|October 5, 2020
Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast CancerShengnan Bao, Yi Chen, Fan Yang, et al.
Frontiers in Immunology|August 8, 2022
Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancerMengping Jiang, Xiangyan Wu, Shengnan Bao, et al.
Cancers|September 9, 2022
A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerTianyu Zeng, Chunxiao Sun, Yan Liang, et al.
Cell Death Discovery|April 13, 2022
A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progressionXueqi Yan, Yaozhou He, Shikun Yang, et al.
Annals of Translational Medicine|September 17, 2021
Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trialsShengnan Bao, Yuanping Yue, Yijia Hua, et al.
Cancer Medicine|October 13, 2021
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based studyShengnan Bao, Mengping Jiang, Xi Wang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|January 26, 2026
Maintenance therapy in hormone receptor-positive and human epidermal growth factor receptor 2-positive metastatic breast cancer: a real-world multicenter retrospective studyShengnan Bao, Jia Chen, Yongmei Yin
Ecotoxicology and Environmental Safety|February 24, 2022
Exploration of anti-chromium mechanism of marine Penicillium janthinellum P1 through combinatorial transcriptomic analysis and WGCNAShengnan Bao, Jiawei Mu, Pingchuan Yin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 26, 2024
Clinical, pathological and gene expression profiling of estrogen receptor discordance in breast cancerXi Wang, Shengnan Bao, Mengping Jiang, et al.
The Breast Journal|June 17, 2022
Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding?Caiyun Yan, Jianling Bai, Shengnan Bao, et al.
Frontiers in Pharmacology|October 5, 2020
Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast CancerShengnan Bao, Yi Chen, Fan Yang, et al.
Frontiers in Immunology|August 8, 2022
Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancerMengping Jiang, Xiangyan Wu, Shengnan Bao, et al.
Cancers|September 9, 2022
A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerTianyu Zeng, Chunxiao Sun, Yan Liang, et al.
Cell Death Discovery|April 13, 2022
A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progressionXueqi Yan, Yaozhou He, Shikun Yang, et al.
Annals of Translational Medicine|September 17, 2021
Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trialsShengnan Bao, Yuanping Yue, Yijia Hua, et al.
Cancer Medicine|October 13, 2021
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based studyShengnan Bao, Mengping Jiang, Xi Wang, et al.
Pageof 1